Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Ocular drug delivery: molecules, cells, and genes.

Liu X, Brandt CR, Rasmussen CA, Kaufman PL.

Can J Ophthalmol. 2007 Jun;42(3):447-54. Review.

PMID:
17508043
2.

Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases.

Pepose JS, Leib DA.

Invest Ophthalmol Vis Sci. 1994 May;35(6):2662-6. Review. No abstract available.

PMID:
8188460
3.

Gene therapy for ocular diseases.

Liu MM, Tuo J, Chan CC.

Br J Ophthalmol. 2011 May;95(5):604-12. doi: 10.1136/bjo.2009.174912. Review.

4.

Treatment of ocular disorders by gene therapy.

Solinís MÁ, del Pozo-Rodríguez A, Apaolaza PS, Rodríguez-Gascón A.

Eur J Pharm Biopharm. 2015 Sep;95(Pt B):331-42. doi: 10.1016/j.ejpb.2014.12.022. Review.

PMID:
25536112
5.

Dendrimers for gene delivery--a potential approach for ocular therapy?

Chaplot SP, Rupenthal ID.

J Pharm Pharmacol. 2014 Apr;66(4):542-56. doi: 10.1111/jphp.12104. Review.

PMID:
24635556
6.

Biological delivery approaches for gene therapy: strategies to potentiate efficacy and enhance specificity.

Mohit E, Rafati S.

Mol Immunol. 2013 Dec;56(4):599-611. doi: 10.1016/j.molimm.2013.06.005. Review.

PMID:
23911418
7.

Nanocarriers in ocular drug delivery: an update review.

Wadhwa S, Paliwal R, Paliwal SR, Vyas SP.

Curr Pharm Des. 2009;15(23):2724-50. Review.

PMID:
19689343
8.

New therapies for the failing heart: trans-genes versus trans-cells.

Lionetti V, Recchia FA.

Transl Res. 2010 Sep;156(3):130-5. doi: 10.1016/j.trsl.2010.06.009. Review.

PMID:
20801409
9.

Stem cell-mediated gene delivering for the treatment of cerebral ischemia: progress and prospectives.

Chen C, Wang Y, Yang GY.

Curr Drug Targets. 2013 Jan 1;14(1):81-9. Review.

PMID:
23170799
10.

Novel possible pharmaceutical research tools: stem cells, gene delivery and their combination.

Varga G, Bori E, Kállo K, Nagy K, Tarján I, Rácz GZ.

Curr Pharm Des. 2013;19(1):133-41. Review.

PMID:
22950495
11.

Cell-based therapies for ocular disease.

Eveleth DD.

J Ocul Pharmacol Ther. 2013 Dec;29(10):844-54. doi: 10.1089/jop.2013.0028. Review.

PMID:
24050306
12.

Delivery strategies for treatment of age-related ocular diseases: From a biological understanding to biomaterial solutions.

Delplace V, Payne S, Shoichet M.

J Control Release. 2015 Dec 10;219:652-68. doi: 10.1016/j.jconrel.2015.09.065. Review.

PMID:
26435454
13.

Ocular Gene Therapy-The Future Is Now.

Huang SS, High K, Toso R.

Asia Pac J Ophthalmol (Phila). 2016 Jul-Aug;5(4):227-8. doi: 10.1097/APO.0000000000000216. No abstract available.

14.

Cell-based therapies for ocular inflammation.

Forrester JV, Steptoe RJ, Klaska IP, Martin-Granados C, Dua HS, Degli-Esposti MA, Wikstrom ME.

Prog Retin Eye Res. 2013 Jul;35:82-101. doi: 10.1016/j.preteyeres.2013.02.002. Review.

PMID:
23542232
15.

Gene therapy in ocular diseases.

Singh VK, Tripathi P.

Indian J Ophthalmol. 2002 Sep;50(3):173-81. Review.

16.

Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases.

Suen CM, Mei SH, Kugathasan L, Stewart DJ.

Compr Physiol. 2013 Oct;3(4):1749-79. doi: 10.1002/cphy.c120034. Review.

PMID:
24265244
17.

Nanotechnology approaches for ocular drug delivery.

Xu Q, Kambhampati SP, Kannan RM.

Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):26-37. doi: 10.4103/0974-9233.106384. Review.

18.

Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.

Ralph GS, Binley K, Wong LF, Azzouz M, Mazarakis ND.

Clin Sci (Lond). 2006 Jan;110(1):37-46. Review.

PMID:
16336203
19.

A review of gene and stem cell therapy in cutaneous wound healing.

Branski LK, Gauglitz GG, Herndon DN, Jeschke MG.

Burns. 2009 Mar;35(2):171-80. doi: 10.1016/j.burns.2008.03.009. Review.

20.

Ex vivo gene therapy and vision.

Gregory-Evans K, Bashar AM, Tan M.

Curr Gene Ther. 2012 Apr 1;12(2):103-15. Review.

PMID:
22424554

Supplemental Content

Support Center